Factors Associated with Readmission of Pediatric Patients in a Developing Nation

Dinesh Kumar1, Swarnim Swarnim2, Gurleen Sikka3

  • 1Division of Pediatric Cardiology, Post Graduate Institute of Medical Education & Research and Dr Ram Manohar Lohia Hospital, New Delhi, India. dineshkumar169@yahoo.co.in.

Indian Journal of Pediatrics
|September 21, 2018
PubMed

Insights

Pediatric readmissions in developing nations are often linked to the initial illness and social factors. Addressing these can help prevent future hospitalizations.

Area of Science:

  • Pediatric Healthcare
  • Public Health
  • Epidemiology

Background:

  • Hospital readmissions in pediatric patients are a significant concern, particularly in developing nations.
  • Understanding the factors contributing to readmission is crucial for improving patient outcomes and healthcare resource allocation.

Purpose of the Study:

  • To determine the incidence of pediatric readmissions in a tertiary care hospital in a developing country.
  • To identify patient-specific and hospital-specific factors associated with these readmissions.

Main Methods:

  • A prospective study was conducted over one year at a tertiary care hospital.
  • Included were pediatric patients aged 1 month to 15 years readmitted within 60 days of discharge.
  • Risk factors were assessed through medical record review and questionnaires, categorizing causes as patient-specific, hospital-specific, or unrelated.

Main Results:

  • The overall pediatric readmission rate was 3%, with 80.66% causally linked to the initial admission.
  • Significant risk factors included sociodemographic characteristics (low socioeconomic status, lack of health information, migration) and patient factors (cardiac disease, anemia, malnutrition, developmental delay).
  • Patient-specific factors (48.66%) were the leading cause of readmission, followed by hospital-specific factors (38%).

Conclusions:

  • The progression of primary illness and social determinants are key contributors to pediatric readmissions in developing countries.
  • Further multicentric studies are recommended to assess readmission rates across different hospitals and explore preventability.
  • Interventions targeting social determinants and patient-specific factors may reduce pediatric readmissions.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
264
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
311
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
233
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
301
Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
327
National Nursing Organizations I01:26

National Nursing Organizations I

Nursing organizations assume a significant role in consistently developing the nursing profession through education, research studies, establishing practice standards, and reforming health policies. Typically, nursing organizations operate at the regional, national, and international levels. For example, the International Council of Nurses (ICN) represents more than 28 million nurses worldwide. In contrast, the American Nurses Association (ANA) is a membership organization representing nurses...
3.1K